> AGN did spend $230M for Oculex so it's nice to see the technology may have some use after all.<
The Posurdex program in DME is pretty far along, so AGN could yet derive some decent value from the Oculex deal. They don’t talk much about Posurdex, however; mainly, they mention it only when asked.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”